Search results for "biomarqueur"

showing 10 items of 16 documents

DIAGSOL : development of a new functional marker of exposure to herbicides B-triketones in an agricultural soil

2020

Numerous herbicides target an enzyme found not only in weeds but also in « non-target organisms » such as microorganisms. This proof-of-concept study aims to use microbial gene encoding the targeted enzyme or the targeted enzyme itself as a marker for herbicide exposure in soils. The hppd gene and the encoded enzyme (HPPD; 4-hydroxyphenylpyruvate dioxygenase), targeted by B-triketone herbicides, are the subject of this study. In silico analyses reveal that the hppd gene is spread out in all bacterial phyla. Primers specific to this gene were designed. This primer pair is used to measure the abundance, the composition and the diversity of the hppd bacterial community in soil microcosms expos…

[SDV.SA]Life Sciences [q-bio]/Agricultural sciences[SDV.EE]Life Sciences [q-bio]/Ecology environment[SDV.SA] Life Sciences [q-bio]/Agricultural sciencesCommunautés microbiennesMicroorganismsMicrobial communitiesBiomarkerEnzyme HPPDOrganismes non-ciblesHPPD enzymeHerbicides β-Tricétones[SDV.EE] Life Sciences [q-bio]/Ecology environment[SDV.EE.ECO]Life Sciences [q-bio]/Ecology environment/EcosystemsBioessaiBiomarqueurNon-target organisms[SDV.EE.ECO] Life Sciences [q-bio]/Ecology environment/EcosystemsMicrobial hppd geneÉcotoxicologie microbienneBioassayMicroorganismeMicrobial ecotoxicologyΒ-Triketones herbicidesGène hppd microbien
researchProduct

Role of biomarkers in the management of antibiotic therapy : an expert panel review : I - currently available biomarkers for clinical use in acute in…

2013

Abstract In the context of worldwide increasing antimicrobial resistance, good antimicrobial prescribing in more needed than ever; unfortunately, information available to clinicians often are insufficient to rely on. Biomarkers might provide help for decision-making and improve antibiotic management. The purpose of this expert panel review was to examine currently available literature on the potential role of biomarkers to improve antimicrobial prescribing, by answering three questions: 1) Which are the biomarkers available for this purpose?; 2) What is their potential role in the initiation of antibiotic therapy?; and 3) What is their role in the decision to stop antibiotic therapy? To ans…

medicine.medical_specialtymedicine.drug_class[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]AntibioticsMEDLINEContext (language use)ReviewCritical Care and Intensive Care MedicineProcalcitoninC-reactive proteinsuPARsepsis03 medical and health sciences0302 clinical medicineAntibiotic resistanceemergency medicineAntibiotic therapy[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Medicine030212 general & internal medicineIntensive care medicine030304 developmental biologyddc:6160303 health sciencessepticemie[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]business.industryPresepsin[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieproADMsTREM-1infection3. Good healthSanté publique et épidémiologie[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieBiomarker (medicine)infection;sepsis;emergency medicine;biomarker;procalcitonin;C-reactive protein;sTREM-1;suPAR;proADM;resepsinbiomarker[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieresepsinbusinessbiomarqueurBiomarkersprocalcitonin
researchProduct

Involvment of docosanoïc acid (C22=0), and of very long chain fatty acids (tetracosanoïc acid (C24=0), hexacosanoïc acid (C26=0) in Alzheimer's disea…

2013

In the brain and in the plasma of patients with Alzheimer’s disease (AD), marked accumulation of C22:0 and of very long chain fatty acids (C24:0 ; C26:0) have been reported. Important decreases of docosahexaenoic acid (DHA; C22:6 n-3) have also been described as well as quantitative and qualitative modifications of plasmalogens. Altogether, these lipid modifications suggest an implication of peroxisomal metabolism disorders in the physiopathology of AD. Therefore, the biological activities of C22:0, C24:0 and C26:0 have been studied on human neuronal cells SK-N-BE. On these cells, the lipotoxicity of fatty acids (C22:0, C24:0 and C26:0) leads to various cellular modifications: topographical…

Biomarqueurs[SDV.SA] Life Sciences [q-bio]/Agricultural sciences[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyHexacosanoic acid (C26:0)Acide hexacosanoique (C26:0)Souris transgénique APP PS1 ΔE9Transgenic mouse APP PS1 ΔE9PeroxisomeMaladie d’AlzheimerAcides gras à très longue chaîneVery long chain fatty acidsLipotoxicitéTetracosanoic acid (C24:0)Docosanoic acid (C22:0)DemenciaDémencesAcide tétracosanoique (C24:0)PeroxysomeAcide docosanoIque (C22:0)Alzheimer’s diseaseBiomarkersLipotoxicity
researchProduct

Sur la piste des matériaux organiques grâce à la spectrométrie de masse

2018

Identifying the organic materials present, establishing their origin and degree of preservation, understanding their manufacturing process and their use, all of which require interdisciplinary studies involving closely specialists in materials and human sciences. In this very specific context, mass spectrometry has become a key tool to improve knowledge of past civilizations but also to better preserve and restore the discrete remains of archaeomaterials. The identification of diagnostic molecular markers of natural substances is now a recognized strategy for characterizing amorphous organic materials (fats, beeswaxes, vegetable substances such as resins and tars). New advances have also ma…

mobilier métalliquematériau organique archéologique[CHIM.ANAL] Chemical Sciences/Analytical chemistry[SHS.ARCHEO] Humanities and Social Sciences/Archaeology and Prehistory[SHS.ARCHEO]Humanities and Social Sciences/Archaeology and Prehistory[SHS.MUSEO] Humanities and Social Sciences/Cultural heritage and museology[CHIM.ANAL]Chemical Sciences/Analytical chemistryaltérationidentification moléculaireSpectrométrie de masse[SHS.MUSEO]Humanities and Social Sciences/Cultural heritage and museologybiomarqueursanalyse chimique
researchProduct

DIAGSOL : Développement d’un outil microbien pour évaluer l’exposition des sols agricoles aux herbicides β-tricétones

2018

International audience; En 2011, en France, plus de 2 millions d’hectares de champs de maïs ont été traités avec desherbicides β-tricétones. Qualifiés de « respectueux de l’environnement » en raison d’une efficacité àfaible dose, de récentes études ont démontré un effet transitoire des β-tricétones sur la diversitébactérienne des sols (Romdhane et al., 2016). L’utilisation récurrente des β-tricétones pourrait, àterme, perturber la diversité bactérienne et les fonctions écosystémiques des sols qu’elle soutient.Il est essentiel d’évaluer l’exposition des microorganismes des sols aux β-tricétones.L’enzyme 4-hydroxyphénylpyruvate dioxygénase (4-HPPD), cible de ces herbicides chez les plantesadv…

communautés microbiennes telluriques[SDE] Environmental Sciencesherbicides β-tricétones[SDE]Environmental Sciencesgène hppdbiomarqueur
researchProduct

Identification of a circulating biomarker highly associated to retinal omega-3 polyunsaturated fatty acid content: the BLISAR project

2019

International audience

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organsrétinelipides[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organshumainbiomarqueur[SDV.AEN]Life Sciences [q-bio]/Food and NutritionComputingMilieux_MISCELLANEOUS
researchProduct

Association of a predictor of retinal omega-3 polyunsaturated fatty acids with advanced age-related macular degeneration: the BLISAR project

2019

International audience

[SDV.AEN] Life Sciences [q-bio]/Food and Nutrition[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organsrétinelipides[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organshumainbiomarqueur[SDV.AEN]Life Sciences [q-bio]/Food and NutritionComputingMilieux_MISCELLANEOUS
researchProduct

Chirurgie cardiaque sous circulation extra-corporelle et ses biomarqueurs : rôle du Growth / Différentiation Factor 15 (GDF 15) : études cliniques

2016

Ischemic cardiac diseases are the most frequent and deleterious pathologies leading to important cardiovascular-related mortality worldwide. One of the alternative therapies consists to treat these patients using cardiac surgery. Cardiopulmonary bypass was developed to greatly improve this surgical procedure. However, some adverse effects can occur during cardiac surgery associated with cardiopulmonary bypass due to the inflammatory response. This phenomenon is the result of various mechanisms including oxidative stress and inflammatory cytokines which lead to multi-organ failure and then to myocardial and renal injuries occurring during the peri- and post-operative periods.The first part o…

Inflammation[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyChirurgie cardiaqueInsuffisance rénale aigue[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciencesCirculation extracorporelleStratification du risqueAcute kidney injuryGDF-15[SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciencesThoracic surgery[ SDV.SP ] Life Sciences [q-bio]/Pharmaceutical sciencesBiomarqueurGrowth differentiation factor 15[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyExtracorporeal circulation[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyBiomarkersRisk assessment
researchProduct

Low level activity thresholds for changes in NMR biomarkers and genes in high risk subjects for type 2 diabetes

2017

AbstractOur objectives were to determine if there are quantitative associations between amounts and intensities of physical activities (PA) on NMR biomarkers and changes in skeletal muscle gene expressions in subjects with high risk for type 2 diabetes (T2D) performing a 3-month PA intervention. We found that PA was associated with beneficial biomarker changes in a factor containing several VLDL and HDL subclasses and lipids in principal component analysis (P = <0.01). Division of PA into quartiles demonstrated significant changes in NMR biomarkers in the 2nd - 4th quartiles compared to the 1st quartile representing PA of less than 2850 daily steps (P = 0.0036). Mediation analysis of PA-…

0301 basic medicineBlood GlucoseMaleVery low-density lipoprotein[SDV]Life Sciences [q-bio]prévention des maladieslcsh:MedicineAdipose tissueMuscle ProteinsType 2 diabetes030204 cardiovascular system & hematologyOverweight0302 clinical medicinemaladie cardiovasculairelcsh:ScienceComputingMilieux_MISCELLANEOUSBODY-WEIGHT CHANGEMultidisciplinaryMiddle AgedMagnetic Resonance Imaging[SDV] Life Sciences [q-bio]ADIPOSE-TISSUEBiomarker (medicine)SKELETAL-MUSCLEFemalemedicine.symptombiomarqueurINSULIN-RESISTANCE ATHEROSCLEROSISAutre (Sciences du Vivant)Adultmedicine.medical_specialtydiabète de type 2expression géniqueCarbohydrate metabolismALL-CAUSEArticle03 medical and health sciencesMedical researchLIPID-METABOLISMInternal medicineDiabetes mellitusmedicineAPOLIPOPROTEIN-D POLYMORPHISMHumansObesityNUCLEAR-MAGNETIC-RESONANCEMuscle SkeletalExercisebusiness.industryMORTALITYlcsh:RLipid metabolismsurpoidsLIPOPROTEIN PARTICLE-SIZEmedicine.disease030104 developmental biologyEndocrinologyPHYSICAL-ACTIVITYDiabetes Mellitus Type 2Gene Expression Regulationlcsh:QbusinessBiomarkers
researchProduct

Dépistage du cancer du sein : en route vers le futur

2016

Breast cancer remains a potentially lethal disease, which requires aggressive treatments and is associated with long-term consequences. Its prognosis is linked to both tumor biology and burden at diagnosis. Although treatments have allowed important improvements in prognosis over the past 20 years, breast cancer screening remains necessary. Mammographic screening allows earlier stage diagnoses and a decrease of breast cancer specific mortality. However, breast cancer screening modalities should be revised with the objective to address demonstrated limitations of mammographic screening (limited benefit, imperfect sensitivity and specificity, overdiagnoses, radiation-induced morbidity). Furth…

RiskCancer Researchmedicine.medical_specialtyPersonalized[SDV.CAN]Life Sciences [q-bio]/CancerDiseaseRisque03 medical and health sciencesBreast cancer screening0302 clinical medicineBreast cancerBreast cancer[SDV.CAN] Life Sciences [q-bio]/CancerPersonnalisémedicineMammographyRadiology Nuclear Medicine and imaging030212 general & internal medicineIntensive care medicineScreening proceduresCancer du seinBiomarqueursCancer preventionmedicine.diagnostic_testbusiness.industryHematologyGeneral Medicinemedicine.disease3. Good healthClinical trialOncologyDépistage030220 oncology & carcinogenesisScreeningBiomarker (medicine)businessBiomarkers
researchProduct